Clinical Trial Update: Evaluating Efficacy and Safety of Danazol in Severe Hematologic or Pulmonary Disease Related to Telomeropathy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating danazol for severe hematologic or pulmonary disease related to telomeropathy; current status unclear.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Telomere Disease
• Pulmonary Telomereopathy
• Telomere Biology Disorder
• Telomere Shortening-related Disease

Drugs mentioned

• Danazol (danazol)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Telomere Shortening, Telomere Length, Mean Leukocyte | Phase 1, Phase 2 | Status: UNKNOWN